Atlas Trials

Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (Reminyl®)

Clinical trial NCT00523666 · UNKNOWN

Trial details

NCT number
NCT00523666
Sponsor
Ludwig-Maximilians - University of Munich
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2006-09-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.